BIOVENTUS INC. - CLASS A COMMON STOCK
10,67
10-февраля-25 11:51:29
15 мин. задержка
Акции
+0,13
+1,23%
Сегодняшний диапазон
10,59 - 10,74
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference
07 янв 2025 08:00:01 Источник Nasdaq GlobeNewswire
-
Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
02 янв 2025 08:00:00 Источник Nasdaq GlobeNewswire
-
Bioventus Reports Third Quarter Financial Results
05 ноя 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
29 окт 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
01 окт 2024 09:00:01 Источник Nasdaq GlobeNewswire
-
Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
07 авг 2024 16:15:00 Источник Nasdaq GlobeNewswire
-
Bioventus Reports Second Quarter Financial Results
06 авг 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
30 июл 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Bioventus Reports First Quarter Financial Results
07 май 2024 07:00:01 Источник Nasdaq GlobeNewswire
-
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
29 апр 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
12 мар 2024 07:30:01 Источник Nasdaq GlobeNewswire
-
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
04 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
18 янв 2024 16:15:00 Источник Nasdaq GlobeNewswire
-
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
12 янв 2024 16:15:00 Источник Nasdaq GlobeNewswire
-
Bioventus Names Robert Claypoole as President and Chief Executive Officer
19 дек 2023 16:30:00 Источник Nasdaq GlobeNewswire
-
06 дек 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
07 ноя 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023
31 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Bioventus to Present at the Cantor Global Healthcare Conference
19 сен 2023 21:52:45 Источник Nasdaq GlobeNewswire
-
Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
06 сен 2023 16:30:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >